Interpace Biosciences, Inc. (IDXG)
1.08
-0.02
(-1.82%)
USD |
OTCM |
Jan 08, 11:44
Interpace Biosciences Market Cap: 4.783M for Jan. 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| FONAR Corp. | 116.80M |
| XWELL, Inc. | 2.667M |
| ProPhase Labs, Inc. | 1.518M |
| Veracyte, Inc. | 3.474B |
| Insight Molecular Diagnostics, Inc. | 214.12M |
Market Cap Related Metrics
| PE Ratio | 4.015 |
| PS Ratio | 0.4137 |
| Price to Free Cash Flow | 3.915 |
| Price | 1.08 |
| Earnings Yield | 24.91% |
| Operating PE Ratio | 3.797 |
| Normalized PE Ratio | 3.838 |